Bio Path Holdings buy shadow
Start price
04.12.20
/
50%
€2.80
Target price
04.12.21
-
Performance (%)
-81.43%
End price
05.12.21
€0.52
Summary
This prediction ended on 05.12.21 with a price of €0.52. Massive losses of -81.43% were the result for the BUY prediction by shadow. shadow has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bio Path Holdings | - | - | - | - |
iShares Core DAX® | 1.560% | 2.566% | 18.261% | 16.927% |
iShares Nasdaq 100 | 0.517% | 1.894% | 25.521% | 35.441% |
iShares Nikkei 225® | 1.730% | 5.631% | 18.569% | 13.063% |
iShares S&P 500 | 1.482% | 1.594% | 24.989% | 38.339% |
According to shadow what are the pros and cons of Bio Path Holdings for the foreseeable future?
Pros
positive Cash Flow expected
Capable Management
Differentiated customer and product portfolio
Future proof or reliable business model
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
EBIT decline/stagnation expected
Low dividend yield expected
Bad rating
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Bad culture
Little innovation
Few uniques
Growths slower than the competition
Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Significant cyclical dependencies
Little known brand
Comments by shadow for this prediction
In the thread Bio Path Holdings diskutieren
Buy Bio Path Holdings
In the thread Trading Bio Path Holdings
Die von shadow gewählte maximale Laufzeit wurde überschritten